Corymbiferin is one of active constituents, responsible for anti-diabetic properties. Corymbiferin improves antioxidant capacity and carbohydrate metabolism in diabetic rats, along with the improvement of histopathology of livers and pancreatic β cells^[1].

The treatment with Corymbiferin (40 mg/kg; p.o.; male Wistar rats,) reduces the FBG level significantly, similar to the effect of positive metformin on the diabetic rats^[1].
Corymbiferin (400 mg/kg; p.o.) also significantly reduces the blood glucose and shows a similar effect to metformin on oral glucose tolerance test (OGTT)^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

304.25

C₁₅H₁₂O₇

5042-09-1

• Phenols
• Polyphenols

• Phenols
• Xanthones

• 植物
• 其他科

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Liu Z, et al. Hypoglycemic Activity and Antioxidative Stress of Extracts and Corymbiferin from Swertia bimaculata In Vitro and In Vivo. Evid Based Complement Alternat Med. 2013;2013:125416.  [Content Brief]